세계의 동물용 백신 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 백신 유형별, 기술별, 지역별, 경쟁별(2020-2030년)

The Global Veterinary Vaccines Market was valued at USD 8.44 billion in 2024 and is projected to grow at a CAGR of 7.28% through 2030. This market plays a critical role in veterinary healthcare by providing vaccines designed to prevent and manage diseases in both companion animals and livestock. These vaccines are essential for ensuring animal health, maintaining food security, and reducing the risk of zoonotic disease transmission. Growing demand for ethical and sustainable animal products, coupled with advancements in vaccine technology and the rise of platform-based solutions for emerging diseases, are contributing to market expansion. Innovations like the European Medicines Agency's certification of the Innovax vPTMF, a turkey herpesvirus vector platform, demonstrate the industry's commitment to rapid response and improved vaccine accessibility. As awareness around animal health continues to rise, the veterinary vaccines market is poised for strong growth globally.

Key Market Drivers

Growing Awareness of Animal Welfare

Increasing public awareness regarding animal welfare is a key factor driving the veterinary vaccines market. Pet owners are more invested in the health of their animals, prioritizing routine vaccinations to extend the life and quality of their pets. Similarly, in livestock farming, the focus on humane treatment and productivity has prompted producers to adopt preventive healthcare strategies, including vaccination. Ethical consumerism is shaping market demand, as buyers prefer products sourced from healthy and well-treated animals. Regulatory frameworks and animal welfare certifications now often include vaccine requirements as part of disease prevention protocols. A notable development is the European Medicines Agency's 2024 certification of the Innovax vPTMF vaccine platform, which enables rapid customization of vaccines to address emerging threats, bolstering preparedness and public health resilience.

Key Market Challenges

Regulatory Hurdles and Approval Processes

The veterinary vaccines market is significantly impacted by the complex and varying regulatory standards across global regions. Navigating country-specific approval processes presents a substantial challenge for manufacturers, often leading to high compliance costs and extended timelines. Regulatory agencies demand rigorous safety and efficacy evaluations, including detailed preclinical and clinical testing. These requirements, while essential for public and animal health, add layers of complexity that slow down time-to-market for new vaccines. Delays in vaccine registration further hinder growth, especially for companies looking to respond swiftly to evolving disease patterns.

Key Market Trends

Increasing Focus on Preventive Healthcare

An emerging trend across the veterinary landscape is the heightened emphasis on preventive care through vaccination. Both pet owners and livestock producers are increasingly aware of the benefits of immunization in minimizing disease outbreaks, reducing treatment costs, and enhancing animal welfare. Preventive healthcare is now viewed as a strategic investment, particularly in the companion animal sector where routine vaccinations are standard. In livestock operations, preventive vaccination supports herd health and productivity, reducing economic losses linked to illness. This trend is reshaping the approach to animal care, prioritizing early intervention and long-term health maintenance.

Key Market Players

• Zoetis Inc.
• Merck & Co. Inc.
• Virbac SA
• Hester Biosciences Limited
• Elanco Animal Health
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Phibro Animal Health Corporation
• HIPRA

Report Scope:

In this report, the Global Veterinary Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Vaccines Market, By Vaccine Type:

• Livestock Vaccine
• Companion Animal Vaccine

Veterinary Vaccines Market, By Technology:

• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other

Veterinary Vaccines Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Vaccines Market.

Available Customizations:

Global Veterinary Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries

4. Overview of Market Drivers, Challenges, Trends

5. Voice of Customer

6. Global Veterinary Vaccines Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Vaccine Type (Livestock Vaccine, Companion Animal Vaccine)
  • 6.2.2. By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other)
  • 6.2.3. By Region
  • 6.2.4. By Company (2024)
• 6.3. Market Map

7. North America Veterinary Vaccines Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Vaccine Type
  • 7.2.2. By Technology
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Veterinary Vaccines Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Vaccine Type
      • 7.3.1.2.2. By Technology
  • 7.3.2. Canada Veterinary Vaccines Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Vaccine Type
      • 7.3.2.2.2. By Technology
  • 7.3.3. Mexico Veterinary Vaccines Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Vaccine Type
      • 7.3.3.2.2. By Technology

8. Europe Veterinary Vaccines Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Vaccine Type
  • 8.2.2. By Technology
  • 8.2.3. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. Germany Veterinary Vaccines Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Vaccine Type
      • 8.3.1.2.2. By Technology
  • 8.3.2. United Kingdom Veterinary Vaccines Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Vaccine Type
      • 8.3.2.2.2. By Technology
  • 8.3.3. Italy Veterinary Vaccines Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecasty
      • 8.3.3.2.1. By Vaccine Type
      • 8.3.3.2.2. By Technology
  • 8.3.4. France Veterinary Vaccines Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Vaccine Type
      • 8.3.4.2.2. By Technology
  • 8.3.5. Spain Veterinary Vaccines Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Vaccine Type
      • 8.3.5.2.2. By Technology

9. Asia-Pacific Veterinary Vaccines Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Vaccine Type
  • 9.2.2. By Technology
  • 9.2.3. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Veterinary Vaccines Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Vaccine Type
      • 9.3.1.2.2. By Technology
  • 9.3.2. India Veterinary Vaccines Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Vaccine Type
      • 9.3.2.2.2. By Technology
  • 9.3.3. Japan Veterinary Vaccines Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Vaccine Type
      • 9.3.3.2.2. By Technology
  • 9.3.4. South Korea Veterinary Vaccines Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Vaccine Type
      • 9.3.4.2.2. By Technology
  • 9.3.5. Australia Veterinary Vaccines Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Vaccine Type
      • 9.3.5.2.2. By Technology

10. South America Veterinary Vaccines Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Vaccine Type
  • 10.2.2. By Technology
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Veterinary Vaccines Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Vaccine Type
      • 10.3.1.2.2. By Technology
  • 10.3.2. Argentina Veterinary Vaccines Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Vaccine Type
      • 10.3.2.2.2. By Technology
  • 10.3.3. Colombia Veterinary Vaccines Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Vaccine Type
      • 10.3.3.2.2. By Technology

11. Middle East and Africa Veterinary Vaccines Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Vaccine Type
  • 11.2.2. By Technology
  • 11.2.3. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Veterinary Vaccines Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Vaccine Type
      • 11.3.1.2.2. By Technology
  • 11.3.2. Saudi Arabia Veterinary Vaccines Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Vaccine Type
      • 11.3.2.2.2. By Technology
  • 11.3.3. UAE Veterinary Vaccines Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Vaccine Type
      • 11.3.3.2.2. By Technology

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Product Launches
• 13.3. Mergers & Acquisitions

14. Global Veterinary Vaccines Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Zoetis Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Technology Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck & Co. Inc.
• 15.3. Virbac
• 15.4. Hester Biosciences Limited
• 15.5. Elanco Animal Health
• 15.6. Boehringer Ingelheim International GmbH
• 15.7. Ceva Sante Animale
• 15.8. Phibro Animal Health Corporation
• 15.9. HIPRA

16. Strategic Recommendations

17. About Us & Disclaimer